CN101788538A - Detection method of microcystic toxins and metabolites thereof in organisms - Google Patents

Detection method of microcystic toxins and metabolites thereof in organisms Download PDF

Info

Publication number
CN101788538A
CN101788538A CN201010028952A CN201010028952A CN101788538A CN 101788538 A CN101788538 A CN 101788538A CN 201010028952 A CN201010028952 A CN 201010028952A CN 201010028952 A CN201010028952 A CN 201010028952A CN 101788538 A CN101788538 A CN 101788538A
Authority
CN
China
Prior art keywords
gsh
cys
sample
concentration
chromatographic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201010028952A
Other languages
Chinese (zh)
Inventor
谢平
吴来燕
陈隽
梁高道
马志梅
邓旭伟
张伟
何君
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Hydrobiology of CAS
Original Assignee
Institute of Hydrobiology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Hydrobiology of CAS filed Critical Institute of Hydrobiology of CAS
Priority to CN201010028952A priority Critical patent/CN101788538A/en
Publication of CN101788538A publication Critical patent/CN101788538A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention discloses a detection method of microcystic toxins and metabolites thereof in organisms, which comprises the following steps: 1. finely grinding freeze drying biological tissue samples, and then, adding extraction liquid into ingredients for extracting materials to be detected; 2. enriching and eluting the extraction liquid obtained in the first step through a strong cation exchange SPE cartridge, and then, processing eluting liquid into a water solution used for analysis and detection; 3. using HPLC-MS for determining the nature of the materials to be detected; and 4. using an external reference method for defining the quantity of the materials to be detected. The method of the invention can simultaneously determine the nature and define the quantity for detecting MC-RR, MC-RR-GSH and MC-RR-Cys in the biological samples, the detection results are reliable, the reproduction quality is good, the sensitivity is high, and when being used, the method detects the existence of MC-RR, MC-RR-GSH and MC-RR-Cys in acute toxicity big-headed fish bodies for the first time.

Description

The detection method of Microcystin and metabolic product thereof in a kind of biosome
Technical field
The present invention relates to the qualitative and quantitative detecting method of Microcystin in a kind of biosome and metabolic product thereof, relate in particular in a kind of biosome Microcystin MC-RR and in metabolic process with the bond MC-RR-GSH of reduced glutathione GSH and halfcystine Cys and the qualitative and quantitative detecting method of MC-RR-Cys.The inventive method is applicable to the qualitative and detection by quantitative of Microcystin MC-RR in the biosome and metabolic product MC-RR-GSH and MC-RR-Cys, and be applicable to the research Microcystin in biosome accumulation, transmission and metabolism detoxifcation and the security of aquatic products assessed.
Background technology
Along with the significantly raising of human society yield-power and the continuous increase of population pressure, body eutrophication causes that blue-green alga bloom takes place frequently, and the harmful secondary metabolites of release, Microcystin (microcystins wherein, be called for short MCs) be that the class that produces of blue-green algae is to the bigger hepatotoxin of biotic influence in environment and the fresh water water body, liver is its main target organ, simultaneously MCs also have renal toxicity, genetoxic, embryo and development toxicity (thank flat. historical development of Taihu Lake blue-green algae and wawter bloom disaster. Beijing: Science Press, 2008).MCs can pass through potable water, approach such as food accumulation enter human body, thereby human health is threatened, Yu Shunzhang etc. find to contain in the potable water hepatitis in area of MCs and onset of liver cancer rate apparently higher than the phreatic water crowd (Yu Shunzhang that drinks no toxin by epidemiology survey, Zhao Ning, money woods dawn etc. Chinese tumour magazine, 2001 (23): 96-99).Microcystin directly causes human dead incident to occur in Brazilian Caruaru dialysis center in 1996, because this center has used the water that is subjected to the Microcystin pollution as the kidney water for dialysis, the result has caused 116 people to poison, the serious consequence of 52 people's death (Jochimsen, E.M., Carmichael, W.W., An J., New Eng.J.Med., 1998 (338): 873-878).
Glutathione is a kind of small-molecule peptide material, extensively be present in the biosome, be made up of glutamic acid, halfcystine and 3 amino acid of glycocoll, glutathione has reduced form (GSH) and two kinds of forms of oxidized form (GSSG), accounts for the overwhelming majority with reduced glutathione GSH under physiological condition.Halfcystine (Cys) is a common amino acid in a kind of biosome, can be transformed by the methionine in the body, can transform mutually with cystine.MC-RR is a kind of Microcystin the most general in the lake, subtropics, when having MC-RR to exist in the biosome, metabolism by biosome self, MC-RR can form the MC-RR-GSH bond with reduced glutathione GSH, and the one-step hydrolysis of going forward side by side becomes water-soluble stronger MC-RR-Cys bond (Kondo, F., Ikai, Y., Oka, H., et al., Chem.Res.Toxicol.1992 (5): 591, Pflugmacher S, Wiegand C, BeattieKA,, et al., Environmental Toxicology and Chemistry.2001 (20): 846-852).
At present for MCs, the research of its metabolic product and detoxification processes thereof focuses mostly in experiment in vitro, also be confined to simultaneously qualitative detection, people such as Kondo have synthesized Microcystin-glutathione and halfcystine in conjunction with the product standard items by chemical method preparation first in 1992, studied its toxicity, and by LC-FAB-MS in big mouse liver first qualitative detection arrived Microcystin-glutathione and halfcystine in conjunction with product (Kondo, F., Ikai, Y., Oka, H., et al., Chem.Res.Toxicol.1992 (5): 591-596, Kondo, F., Matsumoto, H., Yamada, S., et al., Chem.Res.Toxicol.1996 (9): 1355-1359), Pflugmacher etc. are by liquid chromatography and the qualitative Microcystin glutathione bond (Pflugmacher, the S. that form by enzymatic in the experiment in vitro of having identified of substance assistant laser desorpted ionized time-of-flight mass spectrometry, Wiegand, C., Oberemm, A., et al., Acta.1998 (1425): 527-533).For the then rare report of the vivo and vitro quantitative examination of Microcystin and metabolic product thereof, because MC-RR and metabolic product MC-RR-GSH thereof and the concentration of MC-RR-Cys in biological sample are very low usually, interfering material is many, at present without any method energy while these three kinds of materials of qualitative and quantitative detection, thereby need set up reliable, stable quantitative analysis method, and, lay the foundation for further studying MC-RR metabolism and detoxification processes thereof in vivo by effective enrichment, separation and purge process realization high sensitivity, high commissioner's attributive analysis.
Summary of the invention
The object of the present invention is to provide the detection method of interior Microcystin of a kind of biosome and metabolic product thereof, this inventive method can be qualitative simultaneously and the detection by quantitative biological sample in Microcystin MC-RR and metabolic product MC-RR-GSH and MC-RR-Cys, testing result is reliable, favorable reproducibility, highly sensitive.
In order to achieve the above object, the present invention by the following technical solutions, this scheme is carried out according to following steps:
1, the extraction of Microcystin MC-RR and metabolic product MC-RR-GSH and MC-RR-Cys: after biological tissue's organ samples freeze drying, place the stone roller alms bowl levigate, then in acetate-disodium ethylene diamine tetraacetate (EDTA) aqueous solution, make histoorgan clasmatosis with Ultrasonic Cell Disruptor, discharge determinand, centrifugal 10min under 12000r/min pipettes supernatant and keeps in Dark Place to clean container then.Repeat to extract twice according to above-mentioned steps, merge three times supernatant;
2, enrichment, isolation and purification: step 1 gained supernatant is realized enrichment and separated with strong cation exchange solid-phase extraction column (specification is 3cc/60mg), eluent evaporate to dryness on Rotary Evaporators of collecting, methyl alcohol with 100v/v% divides three sample dissolution and changes centrifuge tube over to again, evaporate to dryness on Rotary Evaporators, the solid residue that obtains is used for assay determination with deionized water dissolving and constant volume;
3, qualitative analysis: the HPLC-MS coupling, according to MC-RR, the retention time of MC-RR-GSH and MC-RR-Cys standard items and the mass-to-charge ratio m/z of feature fragment ion peak carry out qualitative;
Chromatographic condition: moving phase: A is the formic acid of 0.05v/v%, and B is the formic acid acetonitrile solution of 0.05v/v%; Flow velocity: 0~20.0min is 0.2mL/min, and 20.01~25.0min is 0.3mL/min; Chromatographic column: C18,100mm * 2.1mm ID, 3.5 μ m; Column temperature: 40.0 ℃; Sample disc temperature: 10.0 ℃; Sampling volume is 10 μ L; Elution program: 0min:95v/v%A, 5%v/v%B, 1.0min:65v/v%A, 35v/v%B, 17.0min:55v/v%A, 45v/v%B, 17.5min:30v/v%A, 70v/v%B, 18.0min:5v/v%A, 95v/v%B, 20.0min:5v/v%A, 95v/v%B, 20.01min:95v/v%A, 5v/v%B, 25.0min:95v/v%A, 5v/v%B;
Mass spectrum condition: electro-spray ionization (ESI); Positive ion mode; Nozzle needle voltage is 4.5KV; Lens voltage: MC-RR is 55.50V, and MC-RR-GSH and MC-RR-Cys are 45.50V; Automatic gain control is opened; The sheath gas velocity is 20 units, and this unit is a U.S. Finnigan LCQ system definition, from 0-100; Auxiliary air to close closes; Capillary temperature is 250 ℃;
4, quantitative test: use external standard method, quantitative with chromatographic peak area, preparation MC-RR, MC-RR-GSH and MC-RR-Cys mixing standard specimen series aqueous solution, MC-RR, MC-RR-GSH and MC-RR-Cys concentration range are 0.01~2.5 μ g/mL, with the same chromatographic condition of determinand under direct injected, respectively with MC-RR, the concentration of MC-RR-GSH and MC-RR-Cys is horizontal ordinate, corresponding chromatographic peak area is an ordinate, and the drawing standard curve is carried out quantitatively testing sample by its regression equation.
All freeze drying conditions are at-65 ℃ in the inventive method, and vacuum tightness is dry 48h in the vacuum freeze drier of 0.1mbar.
The inventive method compared with prior art has following advantage and effect:
1, MC-RR, MC-RR-GSH and the MC-RR-Cys in the simultaneously qualitative and detection by quantitative biological sample;
2, to the qualitative of MC-RR, MC-RR-GSH and MC-RR-Cys and detection by quantitative reliable results, favorable reproducibility, highly sensitive;
3, detect the existence of acute contamination bighead body interior MC-RR, MC-RR-GSH and MC-RR-Cys first.
Description of drawings
Fig. 1 and Fig. 2 are respectively the extract behind the blank fish liver mark-on and the total ions chromatogram of aqueous solution mark-on direct injected.Be followed successively by the one-level total ions chromatogram among Fig. 1 from top to bottom, MC-RR-GSH, the secondary total ions chromatogram of MC-RR-Cys and MC-RR is followed successively by the one-level total ions chromatogram from top to bottom among Fig. 2, MC-RR-GSH, the secondary total ions chromatogram of MC-RR-Cys and MC-RR.
Fig. 3 is injected into behind the MC-RR in the 48h content situation of MC-RR, MC-RR-GSH and MC-RR-Cys in its liver for acute contamination bighead.
By Fig. 1 and Fig. 2 as can be seen, the endogenous material in the fish liver is not disturbed the mensuration of MC-RR, MC-RR-GSH and MC-RR-Cys; As seen from Figure 3, injected interior metabolism spontaneous generation MC-RR-GSH of energy and the MC-RR-Cys of passing through of healthy bighead body of MC-RR.
Embodiment
Below in conjunction with specific embodiment the inventive method is described in further detail.
Embodiment 1: the detection method of Microcystin and metabolic product thereof in a kind of biosome the steps include:
1, the extraction of Microcystin MC-RR and metabolic product MC-RR-GSH and MC-RR-Cys: get cryodesiccated fish liver sample 50mg, levigate being placed in the centrifuge tube in grinding alms bowl, add acetate-EDTA aqueous solution of 5mL 5v/v%, wherein EDTA concentration is 0.01mol/L.Continue ultrasonic 3~5min with Ultrasonic Cell Disruptor under 0 ℃, centrifugal 10min under 12000r/min pipettes supernatant and keeps in Dark Place to clean container then.Repeat to extract twice again according to above-mentioned steps, merge above three supernatants and get solution I, it is pure that used glacial acetic acid and disodium ethylene diamine tetraacetate are analysis;
2, the enrichment of determinand, isolation and purification: carry out enrichment in the strong cation exchange solid-phase extraction column (specification 3cc/60mg) that the solution I adding that step 1 is obtained activates in advance, after treating that enrichment finishes, use the formic acid of 3mL 2v/v% successively, the methyl alcohol drip washing of 3mL90v/v% contains the methanol solution wash-out of 15v/v% strong aqua at last with 10mL.Eluent is collected in the 25mL round-bottomed flask, evaporate to dryness on Rotary Evaporators, divide three sample dissolution and change the 1.5mL centrifuge tube over to 1mL 100v/v% methyl alcohol again, evaporate to dryness once more, the solid residue that obtains is with deionized water dissolving and be settled to 100 μ L, be used for assay determination, it is pure that used formic acid, methyl alcohol and strong aqua are analysis;
3, qualitative analysis: the HPLC-MS coupling, according to MC-RR, the retention time of MC-RR-GSH and MC-RR-Cys standard items and the mass-to-charge ratio m/z of feature fragment ion peak carry out qualitative;
The used MC-RR of the inventive method is commercially available environmental analysis solid standard items, and MC-RR-GSH and MC-RR-Cys standard items reference literature method are synthesized (Kondo, F., Ikai, Y., Oka, H., et al., Chem.Res.Toxicol.1992 (5): 592).Preparation MC-RR, MC-RR-GSH and MC-RR-Cys concentration are the mixing standard specimen aqueous solution of 1.0 μ g/mL and as standard reference material testing sample are carried out qualitative analysis.The electro-spray ionization second order ms cracking characteristic ion of MC-RR and metabolin MC-RR-GSH and MC-RR-Cys sees Table 1, MC-RR, and the parent ion of MC-RR-GSH and MC-RR-Cys is respectively 520.06,673.61 and 580.56.
The ESI second order ms cracking characteristic ion of table 1MC-RR and metabolin MC-RR-GSH and MC-RR-Cys
Figure G2010100289526D00041
4, quantitative test: use external standard method, quantitative with chromatographic peak area, preparation MC-RR, MC-RR-GSH and MC-RR-Cys mixing standard specimen series aqueous solution, MC-RR, MC-RR-GSH and MC-RR-Cys concentration range are 0.01~2.5 μ g/mL, with the same chromatographic condition of determinand under direct injected, respectively with MC-RR, the concentration of MC-RR-GSH and MC-RR-Cys is horizontal ordinate, corresponding chromatographic peak area is an ordinate, and the drawing standard curve is carried out quantitatively testing sample by its regression equation.
Embodiment 2: the selectivity of the inventive method, accuracy, precision and sensitivity are investigated:
1, method selectivity: the cryodesiccated sample 50mg of blank fish liver that the HPLC-MS that learns from else's experience detects, with 50 μ LMC-RR, MC-RR-GSH and MC-RR-Cys concentration are 1 μ gmL -1Aqueous solution be added in this blank sample, operate according to the method step of embodiment 1, obtain the MC-RR with same concentrations, the essentially identical secondary total ions chromatogram of MC-RR-GSH and MC-RR-Cys mixed aqueous solution direct injected.This experimental result shows that the endogenous material in the fish liver sample is not disturbed the mensuration of determinand, sees Fig. 1 and Fig. 2;
2, method calibration curve: the cryodesiccated sample 50mg of blank fish liver that the HPLC-MS that learns from else's experience detects, press step 1 and the operation of step 2 method among the embodiment 1, obtain the matrix concentrate sample of a series of extraction and cleanings.The MC-RR that adds variable concentrations in above sample successively, MC-RR-GSH and MC-RR-Cys are mixed with that to be equivalent to the concentration of each determinand in the fish liver be 0.02,0.1,0.2,1.0,2.0,5.0 μ g.g -1Serial mixed aqueous solution, set up calibration curve.With MC-RR, MC-RR-GSH and MC-RR-Cys concentration are horizontal ordinate respectively, and chromatographic peak area is that ordinate obtains calibration curve.MC-RR, MC-RR-GSH and MC-RR-Cys the results are shown in Table 2 at the calibration curve of liver:
Calibration curve (the X: concentration μ gg of table 2MC-RR, MC-RR-GSH and MC-RR-Cys -1, Y: peak area)
Figure G2010100289526D00051
3, recovery of standard addition: the cryodesiccated sample 50mg of blank fish liver that the HPLC-MS that learns from else's experience detects adds basic, normal, high three concentration respectively and (is respectively 0.2,1.0,5.0 μ gg -1) three kinds of determinands, each concentration is carried out 3 sample analyses.By comparing, the ratio of the standard solution direct injected gained peak area that above processed group chromatographic peak area is identical with containing the determinand amount calculates the averaging method recovery of each concentration point, the results are shown in Table 3.
Table 3MC-RR, MC-RR-GSH and the MC-RR-Cys recovery of standard addition in fish liver sample
Figure G2010100289526D00052
4, the precision of method: prepare MC-RR respectively, MC-RR-GSH and MC-RR-Cys are basic, normal, high, and three concentration (are respectively 0.2,1.0,5.0 μ gg -1) fish liver quality control sample (QC), prepare two groups of samples simultaneously, one group of each concentration analysis of sample 5 times, another group sample METHOD FOR CONTINUOUS DETERMINATION 3 days, every day 1 time.Thereby try to achieve the precision of this assay method, represent with the coefficient of variation.The results are shown in Table 4:
MC-RR in the table 4 fish liver, the precision that MC-RR-GSH and MC-RR-Cys measure
Figure G2010100289526D00061
5, method detectability and quantitative limit: mark-on in the blank fish liver that detects through HPLC-MS, measure the blank mark-on of low concentration of 7 repetitions, mark-on concentration is generally 1~5 times of expection method detectability (MDL) value, and handle and measure according to the overall process of method, calculate the standard deviation SD that measures concentration for 7 times again, mark-on concentration is 0.02 μ gg -1, computing method are as follows:
Method detectability=t (n-1, α=0.01)* standard deviation SD
Quantitative limit (LOQ)=2.5 * method detectability
Degree of confidence t wherein (n-1, α=0.01)Be 99%, the t value when degree of freedom is n-1 is tabled look-up and can be got, and is 2.896, and n is the sample number of replicate analysis, the results are shown in Table 5:
MC-RR in the table 5. mark-on liver sample, the detectability of MC-RR-GSH and MC-RR-Cys and quantitative limit
Figure G2010100289526D00062
Embodiment 3: the acute exposure experiment of healthy bighead:
Go into the MC-RR aqueous solution from lumbar injection behind a collection of healthy bighead fasting 48h, the injected dose of MC-RR is 50 μ g/kg body weight, collects the bighead liver sample of injection back 1,3,12,24 and 48h respectively.The sample of collecting is preserved in-20 ℃ of lower seals, and is standby with postlyophilization.The qualitative and quantitative analysis method of setting up according to the inventive method is measured the MC-RR in the bighead liver of the acute contamination of different time respectively, and MC-RR-GSH and MC-RR-Cys the results are shown in Figure 3.

Claims (1)

1. the detection method of Microcystin and metabolic product thereof in the biosome the steps include:
1., take by weighing cryodesiccated biological tissue samples, levigate being placed in the centrifuge tube in grinding alms bowl, acetate-EDTA the aqueous solution that adds 5v/v% according to the ratio of 0.1mL/mg, wherein EDTA concentration is 0.01mol/L, in 0 ℃ of following ultrasonication 3~5min, centrifugal under 12000r/min then, pipette supernatant and to clean container, keep in Dark Place, repeat to extract twice again, merge solution I;
2., carry out enrichment in the strong cation exchange solid-phase extraction column with solution I adding activation in advance, after treating that enrichment finishes, use the formic acid of 2v/v% successively, the methyl alcohol drip washing of 90v/v%, at last with the methanol solution wash-out that contains the 15v/v% strong aqua, eluent is collected in the round-bottomed flask, evaporate to dryness on Rotary Evaporators, methyl alcohol with 100v/v% divides three sample dissolution and changes centrifuge tube over to again, evaporate to dryness on Rotary Evaporators, the solid residue that obtains is used for assay determination with deionized water dissolving and constant volume;
3., qualitative analysis: the HPLC-MS coupling, according to MC-RR, the retention time of MC-RR-GSH and MC-RR-Cys standard items and the mass-to-charge ratio m/z of feature fragment ion peak carry out qualitative;
Chromatographic condition: moving phase: A is the formic acid of 0.05v/v%, and B is the formic acid acetonitrile solution of 0.05v/v%; Flow velocity: 0~20.0min is 0.2mL/min, and 20.01~25.0min is 0.3mL/min; Chromatographic column: C18,100mm * 2.1mm ID, 3.5 μ m; Column temperature: 40.0 ℃; Sample disc temperature: 10.0 ℃; Sampling volume is 10 μ L; Elution program: 0min:95v/v%A, 5%v/v%B, 1.0min:65v/v%A, 35v/v%B, 17.0min:55v/v%A, 45v/v%B, 17.5min:30v/v%A, 70v/v%B, 18.0min:5v/v%A, 95v/v%B, 20.0min:5v/v%A, 95v/v%B, 20.01min:95v/v%A, 5v/v%B, 25.0min:95v/v%A, 5v/v%B;
Mass spectrum condition: electro-spray ionization; Positive ion mode; Nozzle needle voltage is 4.5KV; Lens voltage: MC-RR is 55.50V, and MC-RR-GSH and MC-RR-Cys are 45.50V; Automatic gain control is opened; The sheath gas velocity is 20 units; Auxiliary air to close closes; Capillary temperature is 250 ℃;
4., quantitative test: use external standard method, quantitative with chromatographic peak area, preparation MC-RR, MC-RR-GSH and MC-RR-Cys mixing standard specimen series aqueous solution, MC-RR, MC-RR-GSH and MC-RR-Cys concentration range are 0.01~2.5 μ g/mL, with the same chromatographic condition of determinand under direct injected, respectively with MC-RR, the concentration of MC-RR-GSH and MC-RR-Cys is horizontal ordinate, corresponding chromatographic peak area is an ordinate, and the drawing standard curve is carried out quantitatively testing sample by its regression equation.
CN201010028952A 2010-01-11 2010-01-11 Detection method of microcystic toxins and metabolites thereof in organisms Pending CN101788538A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010028952A CN101788538A (en) 2010-01-11 2010-01-11 Detection method of microcystic toxins and metabolites thereof in organisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010028952A CN101788538A (en) 2010-01-11 2010-01-11 Detection method of microcystic toxins and metabolites thereof in organisms

Publications (1)

Publication Number Publication Date
CN101788538A true CN101788538A (en) 2010-07-28

Family

ID=42531830

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010028952A Pending CN101788538A (en) 2010-01-11 2010-01-11 Detection method of microcystic toxins and metabolites thereof in organisms

Country Status (1)

Country Link
CN (1) CN101788538A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103197021A (en) * 2013-04-09 2013-07-10 上海海洋大学 Method for detecting microcystic toxins MC-LR in organism
CN107389825A (en) * 2017-08-11 2017-11-24 浙江省食品药品检验研究院 The method that algae toxin in water is determined based on full-automatic on-line solid phase extraction ultra performance liquid chromatography linear ion hydrazine tandem mass spectrum

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103197021A (en) * 2013-04-09 2013-07-10 上海海洋大学 Method for detecting microcystic toxins MC-LR in organism
CN107389825A (en) * 2017-08-11 2017-11-24 浙江省食品药品检验研究院 The method that algae toxin in water is determined based on full-automatic on-line solid phase extraction ultra performance liquid chromatography linear ion hydrazine tandem mass spectrum
CN107389825B (en) * 2017-08-11 2020-07-07 浙江省食品药品检验研究院 Method for determining algae toxins in water based on full-automatic online solid-phase extraction-ultra-high performance liquid chromatography-linear ion trap tandem mass spectrometry

Similar Documents

Publication Publication Date Title
Condrat et al. Qualitative and quantitative analysis of gallic acid in Alchemilla vulgaris, Allium ursinum, Acorus calamus and Solidago virga-aurea by chip-electrospray ionization mass spectrometry and high performance liquid chromatography
CN101458238B (en) Method for detecting Clenbuterol residual quantity in hair
Kamankesh et al. Fast and sensitive low density solvent-based dispersive liquid–liquid microextraction method combined with high-performance liquid chromatography for determining cholecalciferol (vitamin D3) in milk and yogurt drink samples
Glavnik et al. TLC and HPLC screening of p-coumaric acid, trans-resveratrol, and pterostilbene in bacterial cultures, food supplements, and wine
Sun et al. Determination of gentamicin C components in fish tissues through SPE-Hypercarb-HPLC-MS/MS
Chen et al. Determination of ellagic acid in wine by solid-phase extraction–ultra-high performance liquid chromatography–tandem mass spectrometry
Bai et al. Characterization and evaluation of two-dimensional microfluidic chip-HPLC coupled to tandem mass spectrometry for quantitative analysis of 7-aminoflunitrazepam in human urine
CN101788538A (en) Detection method of microcystic toxins and metabolites thereof in organisms
Kulikovskii et al. Determination of growth hormones (β-agonists) in muscle tissue by HPLC with mass spectrometric detection
Móricz et al. Applicability of the BioArena system to investigation of the mechanisms of biological effects
Tie et al. HPLC–ICP-MS analysis of selenium speciation in selenium-enriched Cordyceps militaris
Nirogi et al. Quantification of pramipexole in human plasma by liquid chromatography tandem mass spectrometry using tamsulosin as internal standard
CN111505179A (en) Method for detecting biopterin in marine water body
Zhang et al. Development of a validated direct injection-liquid chromatographic tandem mass spectrometric method under negative electrospray ionization for quantitation of nine microcystins and nodularin-R in lake water
Liu et al. Determination of corosolic acid, a natural potential anti-diabetes compound, in rat plasma by high-performance liquid chromatography-mass spectrometry and its application to pharmacokinetic and bioavailability studies
RU2769094C1 (en) Method for identification and quantitative determination of 20e-ecdysteroids in food raw materials and extracts from it
Bodur et al. Assessment of different isotope dilution strategies and their combination with switchable solvent-based liquid phase microextraction prior to the quantification of bisphenol A at trace levels via GC-MS
CN110590612B (en) Preparation method of high-purity L-PFOS and high-purity L-PFOS
Chen et al. Ion chromatography tandem mass spectrometry for simultaneous confirmation and determination of indandione rodenticides in serum
Lee et al. A convenient HPLC/ELSD method for the quantitative analysis of betaine in Lycium chinense
Chua et al. Effect of absorbent in solid‐phase extraction on quantification of phospholipids in palm‐pressed fiber
RU2810636C1 (en) Method of semiquantitative determination of triterpene acids in siberian fir tree green extracts by liquid chromatography-mass spectrometry method
CN104297329B (en) One kind is applied to the detection of fatty acid molecule qualitative and quantitative analysis and high flux screening Contrast agent box and its preparation
CN104215682B (en) One kind is applied to the detection of amino acid molecular qualitative and quantitative analysis and high flux screening kit and its preparation
Alhealy et al. Determination of amino acids by different methods

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Chen Juan

Inventor after: Wu Laiyan

Inventor after: Xie Ping

Inventor after: Liang Gaodao

Inventor after: Ma Zhimei

Inventor after: Deng Xuwei

Inventor after: Zhang Wei

Inventor after: He Jun

Inventor before: Xie Ping

Inventor before: Wu Laiyan

Inventor before: Chen Juan

Inventor before: Liang Gaodao

Inventor before: Ma Zhimei

Inventor before: Deng Xuwei

Inventor before: Zhang Wei

Inventor before: He Jun

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: XIE PING WU LAIYAN CHEN JUAN LIANG GAODAO MA ZHIMEI DENG XUWEI ZHANG WEI HE JUN TO: CHEN JUAN WU LAIYAN XIE PING LIANG GAODAO MA ZHIMEI DENG XUWEI ZHANG WEI HE JUN

C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Chen Juan

Inventor after: Wu Laiyan

Inventor after: Xie Ping

Inventor after: Liang Gaodao

Inventor after: Ma Zhimei

Inventor after: Deng Xuwei

Inventor after: Zhang Wei

Inventor after: He Jun

Inventor before: Chen Juan

Inventor before: Wu Laiyan

Inventor before: Xie Ping

Inventor before: Liang Gaodao

Inventor before: Ma Zhimei

Inventor before: Deng Xuwei

Inventor before: Zhang Wei

Inventor before: He Jun

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100728